| Description | RET-IN-25 (compound 6b) is an anticancer RET kinase inhibitor that demonstrates efficacy against medullary thyroid carcinoma (MTC), exhibiting half-maximal inhibitory concentrations (IC50s) of 3.6 μM at 3 days and 3.0 μM at 6 days in TT(C634R) MTC [1]. |
| molecular weight | 435.45 |
| Molecular formula | C22H17N3O5S |
| CAS | 2965703-02-8 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |